In this part of the study, the authors demonstrated the GLP-1R was expressed in mural granulosa cells (MGCs), and its expression was decreased in the PCOS model
received honoraria as a speaker for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elpen, Galenica, GSK, MSD, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi Aventis, Takeda and Vianex
In laboratory settings, GLP-1 is investigated for its potential effects on: GLP-1 is unique due to its extended half-life and strong affinity for GLP-1 receptors , enabling more sustained activity in laboratory studies
While its always important to speak with a healthcare provider to decide whether oral GLP-1s are right for you, you are likely not a candidate if: You are pregnant or planning to become pregnant in the near future